Results 191 to 200 of about 222,937 (306)

A helium-burning white dwarf binary as a supersoft X-ray source. [PDF]

open access: yesNature, 2023
Greiner J   +14 more
europepmc   +1 more source

Copper in cancer: friend or foe? Metabolism, dysregulation, and therapeutic opportunities

open access: yesCancer Communications, EarlyView.
Abstract Copper, one of the essential nutrients for the human body, acts as an electron relay in multiple pathways due to its redox properties. Both deficiencies and excesses of copper lead to cellular fragility. Therefore, it can manifest pro‐ and anti‐cancer properties in tumors. Therefore, it is crucial to clarify the copper activity within the cell.
Dan Shan   +13 more
wiley   +1 more source

Thanatophoric Dysplasia: A Report of 2 Cases with Antenatal Misdiagnosis. [PDF]

open access: yesCase Rep Pediatr, 2022
Audu L   +5 more
europepmc   +1 more source

Leveraging corona virus disease 2019 vaccination to promote hepatitis C screening

open access: yesHepatology Communications, EarlyView., 2022
Abstract Health care initiatives, such as hepatitis C virus (HCV) screening, have been greatly overshadowed by the corona virus disease 2019 (COVID‐19) pandemic. However, COVID‐19 vaccination programs also provide an opportunity to engage with a high volume of people in a health care setting.
Aaron Vanderhoff   +17 more
wiley   +1 more source

Anchored in Sole Ingredient Concentration: Numerical Values and Consumer Perceptions of Healthfulness and Quality

open access: yesJournal of Consumer Behaviour, EarlyView.
ABSTRACT Numerical values often serve as anchors in consumer evaluations, potentially shaping perceptions even in the absence of objective reference points. This research introduces the Concentrated Effect, which posits that numerical values indicating the amount of a sole ingredient in a food product can enhance perceptions of ingredient concentration.
Shahin Sharifi
wiley   +1 more source

Translational Medicine in Alzheimer's Disease: The Journey of Donanemab From Discovery to Clinical Application

open access: yesChronic Diseases and Translational Medicine, EarlyView.
Donanemab, approved by the U.S. FDA in July 2024, targets amyloid plaques in the brain to treat Alzheimer's disease in patients with mild cognitive impairment or mild dementia. ABSTRACT Substantial research has been conducted to identify an efficient treatment for Alzheimer's disease (AD).
Nandhini Jayaprakash   +1 more
wiley   +1 more source

Heterogeneous Electrocatalytic CO2 Reduction by Supported Molecular Catalysts Well Dispersed on Electrode Surface

open access: yesChemElectroChem, EarlyView.
This mini review overviews the most recent advances (2020–2024) in heterogeneous electrocatalytic CO2R by well‐dispersed molecular catalysts on electrode surface, mainly focusing on the impacts of efficient molecule‐level dispersion and rational catalyst‐support interactions on electronic properties, multi‐electron transfer kinetics, and overall ...
Ke Ma, Shiyu Zhang, Weixuan Nie
wiley   +1 more source

Home - About - Disclaimer - Privacy